Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience-Reference-Cited by-同舟云学术

Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience

Published:2023-04 Issue: Volume:72 Page:104582
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Bertozzi Andrea,Mariottini Alice^ORCID,Marchi Leonardo,Cristinzi Maria Di,Nistri Riccardo,Damato Valentina,Mechi Claudia,Barilaro Alessandro,Massacesi Luca,Repice Anna Maria

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference27 articles.

1. COVID-19 vaccination in patients with multiple sclerosis: what we have learnt by February 2021;Achiron;Mult. Scler.,2021

2. Persistence of anti-SARS-CoV-2 Spike IgG antibodies following COVID-19 vaccines;Alharbi;Infect Drug Resist,2022

3. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy;Apostolidis;Nat. Med.,2021

4. Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies;Capone;Neurotherapeutics,2022

5. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis;Di Filippo;J. Neurol. Neurosurg. Psychiatry,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders;Vaccine;2024-10

2. Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis;Journal of the Neurological Sciences;2024-01

3. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose;Journal of Neurology;2023-11-03

4. Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica;Journal of Clinical Medicine;2023-08-25

5. COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece;Journal of Clinical Medicine;2023-08-23